Compare BIO-TECHNE Corp (TECH) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs YieldMax Universe Fund of Option Income ETFs — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.36B), while YieldMax Universe Fund of Option Income ETFs trades at $7.61 (market cap $364M). The key difference: BIO-TECHNE Corp is far larger — about 31.2× YieldMax Universe Fund of Option Income ETFs's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while YieldMax Universe Fund of Option Income ETFs pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 64 Days and YieldMax Universe Fund of Option Income ETFs for 56 Days on average.
| TECH | YMAX | |
|---|---|---|
Market Cap | $11.36B | $364M |
Volume | 5,390,331 | 1,181,378 |
Sector | Health | Income / Options Overlay |
52-Week High | $72.61 | $12.98 |
52-Week Low | $43.31 | $7.27 |
Typical Hold Time | 64 Days | 56 Days |
Enterprise Value | $11.39B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.45, near its 52-week high of $72.70 (Defense World, 2026-09-28), with a slight 0.11% decline over 24 hours. The stock shows a bullish technical signal, supported by moving averages, while fundamentals reveal a high P/E of 62.46 and net income margin of 14.97% for 2025. Recent news highlights shareholder approval of its acquisition by Merck KGaA at $73.00 per share (PRNewsWire, 2026-09-23), a key catalyst for near-term price action.
The outlook is mixed: the acquisition offers upside to the current price, but elevated valuation ratios pose risks if earnings growth falters. Analyst consensus is divided with 46% buy ratings, and net income volatility from 2022-2025 signals execution challenges. Investors should weigh the acquisition premium against fundamental sustainability in a competitive life sciences tools sector.
YMAX trades at $7.61, up 1.06% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF maintains a high distribution yield, paying weekly dividends, though recent news highlights concerns about net asset value erosion. Key support is at $7, with resistance at $8.
The outlook is cautious due to structural risks from the fund-of-funds fee structure and declining share price despite distributions. Opportunities exist for income-focused investors seeking high yield, but principal erosion remains a significant risk. Analyst sentiment is neutral to bearish, emphasizing sustainability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
